Authors: Bedikian, AY Plager, C Stewart, JR O'Brian, CA Herdman, SK Ross, M Papadopoulos, N Eton, O Ellerhorst, J Smith, T

Citation: Ay. Bedikian et al., Phase II evaluation of bryostatin-1 in metastatic melanoma, MELANOMA RE, 11(2), 2001, pp. 183-188

Authors: Bedikian, AY Plager, C Papadopoulos, N Ellerhorst, J Smith, T Benjamin, RS

Citation: Ay. Bedikian et al., A phase II evaluation of Bexarotene (Targretin (R)) capsules in patients with metastatic melanoma, ONCOL REP, 7(4), 2000, pp. 883-886

Authors: Eton, O Buzaid, AC Bedikian, AY Smith, TM Papadopoulos, NE Ellerhorst, JA Hibberts, JL Legha, SS Benjamin, RS

Citation: O. Eton et al., A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy, CANCER, 88(7), 2000, pp. 1703-1709

Authors: Bedikian, AY Legha, SS Eton, O Buzaid, AC Papadopoulos, N Plager, C McIntyre, S Viallet, J

Citation: Ay. Bedikian et al., Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma, ANTI-CANC D, 10(8), 1999, pp. 735-739